Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5092252
Max Phase: Preclinical
Molecular Formula: C36H36N4O2
Molecular Weight: 556.71
Molecule Type: Unknown
Associated Items:
ID: ALA5092252
Max Phase: Preclinical
Molecular Formula: C36H36N4O2
Molecular Weight: 556.71
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=CC[C@H](NCc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCc1ccc(-c2ccccc2)cc1
Standard InChI: InChI=1S/C36H36N4O2/c1-2-11-33(37-23-26-12-5-3-6-13-26)36(42)40-34(22-30-25-38-32-17-10-9-16-31(30)32)35(41)39-24-27-18-20-29(21-19-27)28-14-7-4-8-15-28/h2-10,12-21,25,33-34,37-38H,1,11,22-24H2,(H,39,41)(H,40,42)/t33-,34-/m0/s1
Standard InChI Key: LXPQKLDULJBQNH-HEVIKAOCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 556.71 | Molecular Weight (Monoisotopic): 556.2838 | AlogP: 5.91 | #Rotatable Bonds: 13 |
Polar Surface Area: 86.02 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.74 | CX Basic pKa: 7.85 | CX LogP: 6.25 | CX LogD: 5.67 |
Aromatic Rings: 5 | Heavy Atoms: 42 | QED Weighted: 0.14 | Np Likeness Score: -0.29 |
1. Di Sarno V, Lauro G, Musella S, Ciaglia T, Vestuto V, Sala M, Scala MC, Smaldone G, Di Matteo F, Novi S, Tecce MF, Moltedo O, Bifulco G, Campiglia P, Gomez-Monterrey IM, Snoeck R, Andrei G, Ostacolo C, Bertamino A.. (2021) Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization., 226 [PMID:34571172] [10.1016/j.ejmech.2021.113863] |
Source(1):